nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—KIT—thymus cancer	0.516	1	CbGaD
Sunitinib—Dysfunction thyroid—Octreotide—thymus cancer	0.0326	0.226	CcSEcCtD
Sunitinib—Thyroid disorder—Octreotide—thymus cancer	0.0095	0.0659	CcSEcCtD
Sunitinib—Adrenal insufficiency—Octreotide—thymus cancer	0.00744	0.0516	CcSEcCtD
Sunitinib—Proctalgia—Octreotide—thymus cancer	0.00333	0.0231	CcSEcCtD
Sunitinib—Cholecystitis—Octreotide—thymus cancer	0.00272	0.0188	CcSEcCtD
Sunitinib—Haemorrhoids—Octreotide—thymus cancer	0.00265	0.0184	CcSEcCtD
Sunitinib—Haematoma—Octreotide—thymus cancer	0.00248	0.0172	CcSEcCtD
Sunitinib—Hypothyroidism—Octreotide—thymus cancer	0.00243	0.0169	CcSEcCtD
Sunitinib—Nail disorder—Octreotide—thymus cancer	0.0024	0.0167	CcSEcCtD
Sunitinib—Metrorrhagia—Octreotide—thymus cancer	0.00218	0.0151	CcSEcCtD
Sunitinib—Endocrine disorder—Octreotide—thymus cancer	0.00188	0.013	CcSEcCtD
Sunitinib—Acne—Octreotide—thymus cancer	0.00185	0.0129	CcSEcCtD
Sunitinib—Neoplasm malignant—Octreotide—thymus cancer	0.00183	0.0127	CcSEcCtD
Sunitinib—Viral infection—Octreotide—thymus cancer	0.00173	0.012	CcSEcCtD
Sunitinib—Rectal haemorrhage—Octreotide—thymus cancer	0.00173	0.012	CcSEcCtD
Sunitinib—Oropharyngeal pain—Octreotide—thymus cancer	0.00172	0.0119	CcSEcCtD
Sunitinib—Cellulitis—Octreotide—thymus cancer	0.00172	0.0119	CcSEcCtD
Sunitinib—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00156	0.0108	CcSEcCtD
Sunitinib—Hyperkalaemia—Octreotide—thymus cancer	0.00153	0.0106	CcSEcCtD
Sunitinib—Eructation—Octreotide—thymus cancer	0.00153	0.0106	CcSEcCtD
Sunitinib—Influenza like illness—Octreotide—thymus cancer	0.00151	0.0105	CcSEcCtD
Sunitinib—Candida infection—Octreotide—thymus cancer	0.00149	0.0103	CcSEcCtD
Sunitinib—Mouth ulceration—Octreotide—thymus cancer	0.00141	0.00978	CcSEcCtD
Sunitinib—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0013	0.00903	CcSEcCtD
Sunitinib—Cardiac failure congestive—Octreotide—thymus cancer	0.00125	0.00866	CcSEcCtD
Sunitinib—Nasal congestion—Octreotide—thymus cancer	0.00124	0.00862	CcSEcCtD
Sunitinib—Hot flush—Octreotide—thymus cancer	0.00121	0.00839	CcSEcCtD
Sunitinib—Menopausal symptoms—Octreotide—thymus cancer	0.0012	0.00832	CcSEcCtD
Sunitinib—Hypoglycaemia—Octreotide—thymus cancer	0.00116	0.00805	CcSEcCtD
Sunitinib—Pain in extremity—Octreotide—thymus cancer	0.00113	0.00785	CcSEcCtD
Sunitinib—Dehydration—Octreotide—thymus cancer	0.00105	0.0073	CcSEcCtD
Sunitinib—Dry skin—Octreotide—thymus cancer	0.00104	0.0072	CcSEcCtD
Sunitinib—Abdominal pain upper—Octreotide—thymus cancer	0.00103	0.00717	CcSEcCtD
Sunitinib—Nasopharyngitis—Octreotide—thymus cancer	0.00101	0.00702	CcSEcCtD
Sunitinib—Muscular weakness—Octreotide—thymus cancer	0.000999	0.00693	CcSEcCtD
Sunitinib—Abdominal distension—Octreotide—thymus cancer	0.000985	0.00683	CcSEcCtD
Sunitinib—Pancreatitis—Octreotide—thymus cancer	0.000959	0.00665	CcSEcCtD
Sunitinib—Bronchitis—Octreotide—thymus cancer	0.000941	0.00653	CcSEcCtD
Sunitinib—Abdominal discomfort—Octreotide—thymus cancer	0.000938	0.00651	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Octreotide—thymus cancer	0.000909	0.00631	CcSEcCtD
Sunitinib—Weight decreased—Octreotide—thymus cancer	0.000885	0.00614	CcSEcCtD
Sunitinib—Hyperglycaemia—Octreotide—thymus cancer	0.000883	0.00612	CcSEcCtD
Sunitinib—Pneumonia—Octreotide—thymus cancer	0.000878	0.00609	CcSEcCtD
Sunitinib—Depression—Octreotide—thymus cancer	0.00087	0.00603	CcSEcCtD
Sunitinib—Neuropathy peripheral—Octreotide—thymus cancer	0.000855	0.00593	CcSEcCtD
Sunitinib—Urinary tract infection—Octreotide—thymus cancer	0.000848	0.00588	CcSEcCtD
Sunitinib—Hepatobiliary disease—Octreotide—thymus cancer	0.000825	0.00572	CcSEcCtD
Sunitinib—Epistaxis—Octreotide—thymus cancer	0.000823	0.00571	CcSEcCtD
Sunitinib—Bradycardia—Octreotide—thymus cancer	0.000797	0.00553	CcSEcCtD
Sunitinib—Hepatitis—Octreotide—thymus cancer	0.000783	0.00543	CcSEcCtD
Sunitinib—Hypoaesthesia—Octreotide—thymus cancer	0.000779	0.0054	CcSEcCtD
Sunitinib—Oedema peripheral—Octreotide—thymus cancer	0.000772	0.00535	CcSEcCtD
Sunitinib—Cardiac disorder—Octreotide—thymus cancer	0.000727	0.00504	CcSEcCtD
Sunitinib—Flushing—Octreotide—thymus cancer	0.000727	0.00504	CcSEcCtD
Sunitinib—Immune system disorder—Octreotide—thymus cancer	0.000707	0.00491	CcSEcCtD
Sunitinib—Arrhythmia—Octreotide—thymus cancer	0.0007	0.00485	CcSEcCtD
Sunitinib—Alopecia—Octreotide—thymus cancer	0.000692	0.0048	CcSEcCtD
Sunitinib—Mental disorder—Octreotide—thymus cancer	0.000686	0.00476	CcSEcCtD
Sunitinib—Malnutrition—Octreotide—thymus cancer	0.000682	0.00473	CcSEcCtD
Sunitinib—Erythema—Octreotide—thymus cancer	0.000682	0.00473	CcSEcCtD
Sunitinib—Flatulence—Octreotide—thymus cancer	0.000672	0.00466	CcSEcCtD
Sunitinib—Back pain—Octreotide—thymus cancer	0.00066	0.00457	CcSEcCtD
Sunitinib—Muscle spasms—Octreotide—thymus cancer	0.000656	0.00455	CcSEcCtD
Sunitinib—Anaemia—Octreotide—thymus cancer	0.00063	0.00437	CcSEcCtD
Sunitinib—Cough—Octreotide—thymus cancer	0.000595	0.00413	CcSEcCtD
Sunitinib—Convulsion—Octreotide—thymus cancer	0.000591	0.0041	CcSEcCtD
Sunitinib—Hypertension—Octreotide—thymus cancer	0.000589	0.00408	CcSEcCtD
Sunitinib—Myalgia—Octreotide—thymus cancer	0.00058	0.00403	CcSEcCtD
Sunitinib—Arthralgia—Octreotide—thymus cancer	0.00058	0.00403	CcSEcCtD
Sunitinib—Chest pain—Octreotide—thymus cancer	0.00058	0.00403	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.000576	0.004	CcSEcCtD
Sunitinib—Dry mouth—Octreotide—thymus cancer	0.000568	0.00394	CcSEcCtD
Sunitinib—Oedema—Octreotide—thymus cancer	0.000556	0.00386	CcSEcCtD
Sunitinib—Infection—Octreotide—thymus cancer	0.000553	0.00383	CcSEcCtD
Sunitinib—Shock—Octreotide—thymus cancer	0.000547	0.0038	CcSEcCtD
Sunitinib—Nervous system disorder—Octreotide—thymus cancer	0.000546	0.00378	CcSEcCtD
Sunitinib—Thrombocytopenia—Octreotide—thymus cancer	0.000545	0.00378	CcSEcCtD
Sunitinib—Skin disorder—Octreotide—thymus cancer	0.000541	0.00375	CcSEcCtD
Sunitinib—Anorexia—Octreotide—thymus cancer	0.00053	0.00368	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Octreotide—thymus cancer	0.000507	0.00352	CcSEcCtD
Sunitinib—Insomnia—Octreotide—thymus cancer	0.000503	0.00349	CcSEcCtD
Sunitinib—Paraesthesia—Octreotide—thymus cancer	0.0005	0.00347	CcSEcCtD
Sunitinib—Dyspnoea—Octreotide—thymus cancer	0.000496	0.00344	CcSEcCtD
Sunitinib—Dyspepsia—Octreotide—thymus cancer	0.00049	0.0034	CcSEcCtD
Sunitinib—Decreased appetite—Octreotide—thymus cancer	0.000484	0.00335	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Octreotide—thymus cancer	0.00048	0.00333	CcSEcCtD
Sunitinib—Fatigue—Octreotide—thymus cancer	0.00048	0.00333	CcSEcCtD
Sunitinib—Pain—Octreotide—thymus cancer	0.000476	0.0033	CcSEcCtD
Sunitinib—Constipation—Octreotide—thymus cancer	0.000476	0.0033	CcSEcCtD
Sunitinib—Gastrointestinal pain—Octreotide—thymus cancer	0.000455	0.00316	CcSEcCtD
Sunitinib—Abdominal pain—Octreotide—thymus cancer	0.00044	0.00305	CcSEcCtD
Sunitinib—Body temperature increased—Octreotide—thymus cancer	0.00044	0.00305	CcSEcCtD
Sunitinib—Hypersensitivity—Octreotide—thymus cancer	0.00041	0.00284	CcSEcCtD
Sunitinib—Asthenia—Octreotide—thymus cancer	0.000399	0.00277	CcSEcCtD
Sunitinib—Pruritus—Octreotide—thymus cancer	0.000394	0.00273	CcSEcCtD
Sunitinib—Diarrhoea—Octreotide—thymus cancer	0.000381	0.00264	CcSEcCtD
Sunitinib—Dizziness—Octreotide—thymus cancer	0.000368	0.00255	CcSEcCtD
Sunitinib—Vomiting—Octreotide—thymus cancer	0.000354	0.00245	CcSEcCtD
Sunitinib—Rash—Octreotide—thymus cancer	0.000351	0.00243	CcSEcCtD
Sunitinib—Dermatitis—Octreotide—thymus cancer	0.000351	0.00243	CcSEcCtD
Sunitinib—Headache—Octreotide—thymus cancer	0.000349	0.00242	CcSEcCtD
Sunitinib—Nausea—Octreotide—thymus cancer	0.000331	0.00229	CcSEcCtD
Sunitinib—PTK2B—thyroid gland—thymus cancer	0.000221	0.00115	CbGeAlD
Sunitinib—FLT4—bone marrow—thymus cancer	0.000221	0.00115	CbGeAlD
Sunitinib—ICK—lymph node—thymus cancer	0.00022	0.00115	CbGeAlD
Sunitinib—MAP3K12—lung—thymus cancer	0.00022	0.00115	CbGeAlD
Sunitinib—FLT3—lung—thymus cancer	0.00022	0.00115	CbGeAlD
Sunitinib—FLT4—thyroid gland—thymus cancer	0.00022	0.00115	CbGeAlD
Sunitinib—JAK2—cardiac atrium—thymus cancer	0.000218	0.00114	CbGeAlD
Sunitinib—CSNK1E—thyroid gland—thymus cancer	0.000217	0.00113	CbGeAlD
Sunitinib—FGFR1—thyroid gland—thymus cancer	0.000217	0.00113	CbGeAlD
Sunitinib—RPS6KA3—lung—thymus cancer	0.000217	0.00113	CbGeAlD
Sunitinib—SLK—pituitary gland—thymus cancer	0.000216	0.00113	CbGeAlD
Sunitinib—MAP2K1—lung—thymus cancer	0.000216	0.00112	CbGeAlD
Sunitinib—RPS6KB1—lymphoid tissue—thymus cancer	0.000215	0.00112	CbGeAlD
Sunitinib—FYN—cardiac atrium—thymus cancer	0.000215	0.00112	CbGeAlD
Sunitinib—IRAK4—bone marrow—thymus cancer	0.000214	0.00112	CbGeAlD
Sunitinib—FGR—lymphoid tissue—thymus cancer	0.000214	0.00111	CbGeAlD
Sunitinib—RET—lymphoid tissue—thymus cancer	0.000214	0.00111	CbGeAlD
Sunitinib—IRAK4—thyroid gland—thymus cancer	0.000214	0.00111	CbGeAlD
Sunitinib—AXL—lymphoid tissue—thymus cancer	0.000213	0.00111	CbGeAlD
Sunitinib—JAK2—pituitary gland—thymus cancer	0.000213	0.00111	CbGeAlD
Sunitinib—CSNK1A1—lung—thymus cancer	0.000213	0.00111	CbGeAlD
Sunitinib—CHEK2—lymph node—thymus cancer	0.000213	0.00111	CbGeAlD
Sunitinib—NUAK1—lymph node—thymus cancer	0.000213	0.00111	CbGeAlD
Sunitinib—CLK1—lung—thymus cancer	0.000212	0.0011	CbGeAlD
Sunitinib—OXSR1—lymph node—thymus cancer	0.000211	0.0011	CbGeAlD
Sunitinib—INSR—lymph node—thymus cancer	0.000211	0.0011	CbGeAlD
Sunitinib—SNRK—lymph node—thymus cancer	0.000211	0.0011	CbGeAlD
Sunitinib—MAP4K5—cardiac atrium—thymus cancer	0.00021	0.0011	CbGeAlD
Sunitinib—MAP3K3—cardiac atrium—thymus cancer	0.00021	0.0011	CbGeAlD
Sunitinib—FYN—pituitary gland—thymus cancer	0.00021	0.00109	CbGeAlD
Sunitinib—ULK3—bone marrow—thymus cancer	0.00021	0.00109	CbGeAlD
Sunitinib—MAP2K2—bone marrow—thymus cancer	0.00021	0.00109	CbGeAlD
Sunitinib—MAP2K2—thyroid gland—thymus cancer	0.000209	0.00109	CbGeAlD
Sunitinib—ULK3—thyroid gland—thymus cancer	0.000209	0.00109	CbGeAlD
Sunitinib—MAP3K2—bone marrow—thymus cancer	0.000208	0.00108	CbGeAlD
Sunitinib—STK38—lymph node—thymus cancer	0.000208	0.00108	CbGeAlD
Sunitinib—RPS6KA2—lymph node—thymus cancer	0.000208	0.00108	CbGeAlD
Sunitinib—CAMK2G—lung—thymus cancer	0.000208	0.00108	CbGeAlD
Sunitinib—BMP2K—lung—thymus cancer	0.000208	0.00108	CbGeAlD
Sunitinib—MAP3K2—thyroid gland—thymus cancer	0.000208	0.00108	CbGeAlD
Sunitinib—KDR—epithelium—thymus cancer	0.000207	0.00108	CbGeAlD
Sunitinib—MAP3K7—bone marrow—thymus cancer	0.000206	0.00107	CbGeAlD
Sunitinib—AURKC—lymph node—thymus cancer	0.000206	0.00107	CbGeAlD
Sunitinib—LRRK2—lung—thymus cancer	0.000206	0.00107	CbGeAlD
Sunitinib—MAP3K7—thyroid gland—thymus cancer	0.000206	0.00107	CbGeAlD
Sunitinib—MAP4K5—pituitary gland—thymus cancer	0.000205	0.00107	CbGeAlD
Sunitinib—MAP3K3—pituitary gland—thymus cancer	0.000205	0.00107	CbGeAlD
Sunitinib—CSNK1G2—lymph node—thymus cancer	0.000205	0.00107	CbGeAlD
Sunitinib—PKN1—lymph node—thymus cancer	0.000205	0.00107	CbGeAlD
Sunitinib—TBK1—bone marrow—thymus cancer	0.000204	0.00106	CbGeAlD
Sunitinib—TBK1—thyroid gland—thymus cancer	0.000203	0.00106	CbGeAlD
Sunitinib—FLT1—cardiac atrium—thymus cancer	0.000203	0.00106	CbGeAlD
Sunitinib—PRKAA1—lung—thymus cancer	0.000203	0.00106	CbGeAlD
Sunitinib—TYK2—bone marrow—thymus cancer	0.000202	0.00105	CbGeAlD
Sunitinib—JAK2—lymphoid tissue—thymus cancer	0.000202	0.00105	CbGeAlD
Sunitinib—TYK2—thyroid gland—thymus cancer	0.000202	0.00105	CbGeAlD
Sunitinib—PRPF4—lymph node—thymus cancer	0.000202	0.00105	CbGeAlD
Sunitinib—EPHB6—cardiac atrium—thymus cancer	0.000201	0.00105	CbGeAlD
Sunitinib—KIT—hematopoietic system—thymus cancer	0.000201	0.00104	CbGeAlD
Sunitinib—PTK2B—lung—thymus cancer	0.000201	0.00104	CbGeAlD
Sunitinib—FLT4—lung—thymus cancer	0.0002	0.00104	CbGeAlD
Sunitinib—IRAK1—bone marrow—thymus cancer	0.0002	0.00104	CbGeAlD
Sunitinib—FYN—lymphoid tissue—thymus cancer	0.000199	0.00104	CbGeAlD
Sunitinib—IRAK1—thyroid gland—thymus cancer	0.000199	0.00104	CbGeAlD
Sunitinib—PRPF4B—lymph node—thymus cancer	0.000199	0.00104	CbGeAlD
Sunitinib—FLT1—pituitary gland—thymus cancer	0.000199	0.00103	CbGeAlD
Sunitinib—FGFR1—lung—thymus cancer	0.000197	0.00103	CbGeAlD
Sunitinib—CSNK1E—lung—thymus cancer	0.000197	0.00103	CbGeAlD
Sunitinib—EPHB6—pituitary gland—thymus cancer	0.000196	0.00102	CbGeAlD
Sunitinib—RPS6KB1—bone marrow—thymus cancer	0.000196	0.00102	CbGeAlD
Sunitinib—STK39—lymph node—thymus cancer	0.000196	0.00102	CbGeAlD
Sunitinib—PDGFRB—hematopoietic system—thymus cancer	0.000196	0.00102	CbGeAlD
Sunitinib—RPS6KB1—thyroid gland—thymus cancer	0.000196	0.00102	CbGeAlD
Sunitinib—MAP4K5—lymphoid tissue—thymus cancer	0.000195	0.00102	CbGeAlD
Sunitinib—FGR—bone marrow—thymus cancer	0.000195	0.00102	CbGeAlD
Sunitinib—RET—thyroid gland—thymus cancer	0.000194	0.00101	CbGeAlD
Sunitinib—FGR—thyroid gland—thymus cancer	0.000194	0.00101	CbGeAlD
Sunitinib—IRAK4—lung—thymus cancer	0.000194	0.00101	CbGeAlD
Sunitinib—YES1—cardiac atrium—thymus cancer	0.000194	0.00101	CbGeAlD
Sunitinib—AXL—thyroid gland—thymus cancer	0.000194	0.00101	CbGeAlD
Sunitinib—CSNK2A1—lymph node—thymus cancer	0.000193	0.00101	CbGeAlD
Sunitinib—TAOK3—cardiac atrium—thymus cancer	0.000192	0.000999	CbGeAlD
Sunitinib—MYLK—lymph node—thymus cancer	0.000191	0.000994	CbGeAlD
Sunitinib—ULK3—lung—thymus cancer	0.00019	0.000989	CbGeAlD
Sunitinib—MAP2K2—lung—thymus cancer	0.00019	0.000989	CbGeAlD
Sunitinib—YES1—pituitary gland—thymus cancer	0.00019	0.000988	CbGeAlD
Sunitinib—MAP3K2—lung—thymus cancer	0.000189	0.000982	CbGeAlD
Sunitinib—PLK4—lymph node—thymus cancer	0.000189	0.000982	CbGeAlD
Sunitinib—FLT1—lymphoid tissue—thymus cancer	0.000188	0.000982	CbGeAlD
Sunitinib—STK4—lymph node—thymus cancer	0.000187	0.000976	CbGeAlD
Sunitinib—TAOK3—pituitary gland—thymus cancer	0.000187	0.000976	CbGeAlD
Sunitinib—SLK—bone marrow—thymus cancer	0.000187	0.000973	CbGeAlD
Sunitinib—MAP3K7—lung—thymus cancer	0.000187	0.000973	CbGeAlD
Sunitinib—SLK—thyroid gland—thymus cancer	0.000186	0.000971	CbGeAlD
Sunitinib—FGFR2—thyroid gland—thymus cancer	0.000185	0.000962	CbGeAlD
Sunitinib—TBK1—lung—thymus cancer	0.000185	0.000962	CbGeAlD
Sunitinib—JAK2—bone marrow—thymus cancer	0.000184	0.000959	CbGeAlD
Sunitinib—PHKG2—lymph node—thymus cancer	0.000184	0.000959	CbGeAlD
Sunitinib—JAK2—thyroid gland—thymus cancer	0.000184	0.000957	CbGeAlD
Sunitinib—TYK2—lung—thymus cancer	0.000183	0.000955	CbGeAlD
Sunitinib—KIT—epithelium—thymus cancer	0.000183	0.000955	CbGeAlD
Sunitinib—STK24—lymph node—thymus cancer	0.000183	0.000953	CbGeAlD
Sunitinib—FYN—bone marrow—thymus cancer	0.000182	0.000946	CbGeAlD
Sunitinib—FYN—thyroid gland—thymus cancer	0.000181	0.000944	CbGeAlD
Sunitinib—IRAK1—lung—thymus cancer	0.000181	0.000943	CbGeAlD
Sunitinib—DAPK2—lymph node—thymus cancer	0.000181	0.000943	CbGeAlD
Sunitinib—YES1—lymphoid tissue—thymus cancer	0.00018	0.000938	CbGeAlD
Sunitinib—PDGFRB—epithelium—thymus cancer	0.000179	0.000933	CbGeAlD
Sunitinib—STK10—lymphoid tissue—thymus cancer	0.000178	0.000929	CbGeAlD
Sunitinib—STK16—lymph node—thymus cancer	0.000178	0.000927	CbGeAlD
Sunitinib—TAOK3—lymphoid tissue—thymus cancer	0.000178	0.000926	CbGeAlD
Sunitinib—RPS6KB1—lung—thymus cancer	0.000178	0.000925	CbGeAlD
Sunitinib—MAP4K5—bone marrow—thymus cancer	0.000177	0.000925	CbGeAlD
Sunitinib—MAP3K3—bone marrow—thymus cancer	0.000177	0.000925	CbGeAlD
Sunitinib—HIPK3—lymph node—thymus cancer	0.000177	0.000923	CbGeAlD
Sunitinib—HIPK2—lymph node—thymus cancer	0.000177	0.000923	CbGeAlD
Sunitinib—ALK—lymph node—thymus cancer	0.000177	0.000923	CbGeAlD
Sunitinib—MAP4K5—thyroid gland—thymus cancer	0.000177	0.000922	CbGeAlD
Sunitinib—MAP3K3—thyroid gland—thymus cancer	0.000177	0.000922	CbGeAlD
Sunitinib—PDGFRA—lymphoid tissue—thymus cancer	0.000177	0.00092	CbGeAlD
Sunitinib—FGR—lung—thymus cancer	0.000177	0.00092	CbGeAlD
Sunitinib—AXL—lung—thymus cancer	0.000176	0.000916	CbGeAlD
Sunitinib—TNK1—lymph node—thymus cancer	0.000175	0.000913	CbGeAlD
Sunitinib—RIOK2—lymph node—thymus cancer	0.000175	0.000913	CbGeAlD
Sunitinib—MAP4K1—lymph node—thymus cancer	0.000173	0.000904	CbGeAlD
Sunitinib—KDR—cardiac atrium—thymus cancer	0.000172	0.000895	CbGeAlD
Sunitinib—MAP2K5—cardiac atrium—thymus cancer	0.000172	0.000895	CbGeAlD
Sunitinib—FLT1—thyroid gland—thymus cancer	0.000171	0.000892	CbGeAlD
Sunitinib—DAPK3—lymph node—thymus cancer	0.00017	0.000886	CbGeAlD
Sunitinib—SLK—lung—thymus cancer	0.000169	0.000882	CbGeAlD
Sunitinib—EPHB6—thyroid gland—thymus cancer	0.000169	0.000882	CbGeAlD
Sunitinib—CLK2—lymph node—thymus cancer	0.000169	0.000878	CbGeAlD
Sunitinib—MAP2K5—pituitary gland—thymus cancer	0.000168	0.000875	CbGeAlD
Sunitinib—KDR—pituitary gland—thymus cancer	0.000168	0.000875	CbGeAlD
Sunitinib—MAP4K2—lymph node—thymus cancer	0.000168	0.000874	CbGeAlD
Sunitinib—FGFR2—lung—thymus cancer	0.000168	0.000874	CbGeAlD
Sunitinib—CSF1R—cardiac atrium—thymus cancer	0.000168	0.000874	CbGeAlD
Sunitinib—JAK2—lung—thymus cancer	0.000167	0.000869	CbGeAlD
Sunitinib—STK3—lymph node—thymus cancer	0.000165	0.000862	CbGeAlD
Sunitinib—FYN—lung—thymus cancer	0.000165	0.000857	CbGeAlD
Sunitinib—YES1—bone marrow—thymus cancer	0.000164	0.000854	CbGeAlD
Sunitinib—CSF1R—pituitary gland—thymus cancer	0.000164	0.000853	CbGeAlD
Sunitinib—YES1—thyroid gland—thymus cancer	0.000164	0.000852	CbGeAlD
Sunitinib—STK10—bone marrow—thymus cancer	0.000162	0.000846	CbGeAlD
Sunitinib—STK10—thyroid gland—thymus cancer	0.000162	0.000844	CbGeAlD
Sunitinib—TAOK3—bone marrow—thymus cancer	0.000162	0.000843	CbGeAlD
Sunitinib—TAOK3—thyroid gland—thymus cancer	0.000161	0.000841	CbGeAlD
Sunitinib—MAP4K5—lung—thymus cancer	0.000161	0.000838	CbGeAlD
Sunitinib—MAP3K3—lung—thymus cancer	0.000161	0.000838	CbGeAlD
Sunitinib—PDGFRA—thyroid gland—thymus cancer	0.00016	0.000836	CbGeAlD
Sunitinib—KDR—lymphoid tissue—thymus cancer	0.000159	0.00083	CbGeAlD
Sunitinib—DYRK1A—lymph node—thymus cancer	0.000159	0.00083	CbGeAlD
Sunitinib—ABCC4—hematopoietic system—thymus cancer	0.000156	0.000812	CbGeAlD
Sunitinib—MERTK—lymph node—thymus cancer	0.000156	0.000811	CbGeAlD
Sunitinib—CSF1R—lymphoid tissue—thymus cancer	0.000155	0.00081	CbGeAlD
Sunitinib—FLT1—lung—thymus cancer	0.000155	0.00081	CbGeAlD
Sunitinib—EPHB6—lung—thymus cancer	0.000154	0.000801	CbGeAlD
Sunitinib—MAP4K4—lymph node—thymus cancer	0.000153	0.000796	CbGeAlD
Sunitinib—NUAK2—lymph node—thymus cancer	0.000152	0.00079	CbGeAlD
Sunitinib—FLT3—lymph node—thymus cancer	0.000151	0.000784	CbGeAlD
Sunitinib—MAP3K12—lymph node—thymus cancer	0.000151	0.000784	CbGeAlD
Sunitinib—KIT—pituitary gland—thymus cancer	0.000149	0.000775	CbGeAlD
Sunitinib—PDGFRB—cardiac atrium—thymus cancer	0.000149	0.000775	CbGeAlD
Sunitinib—YES1—lung—thymus cancer	0.000149	0.000774	CbGeAlD
Sunitinib—RPS6KA3—lymph node—thymus cancer	0.000148	0.000774	CbGeAlD
Sunitinib—MAP2K1—lymph node—thymus cancer	0.000148	0.000769	CbGeAlD
Sunitinib—STK10—lung—thymus cancer	0.000147	0.000767	CbGeAlD
Sunitinib—TAOK3—lung—thymus cancer	0.000147	0.000764	CbGeAlD
Sunitinib—PDGFRA—lung—thymus cancer	0.000146	0.000759	CbGeAlD
Sunitinib—CSNK1A1—lymph node—thymus cancer	0.000146	0.000759	CbGeAlD
Sunitinib—PDGFRB—pituitary gland—thymus cancer	0.000145	0.000757	CbGeAlD
Sunitinib—KDR—bone marrow—thymus cancer	0.000145	0.000756	CbGeAlD
Sunitinib—KDR—thyroid gland—thymus cancer	0.000145	0.000754	CbGeAlD
Sunitinib—MAP2K5—thyroid gland—thymus cancer	0.000145	0.000754	CbGeAlD
Sunitinib—CLK1—lymph node—thymus cancer	0.000145	0.000754	CbGeAlD
Sunitinib—BMP2K—lymph node—thymus cancer	0.000142	0.00074	CbGeAlD
Sunitinib—CAMK2G—lymph node—thymus cancer	0.000142	0.00074	CbGeAlD
Sunitinib—CSF1R—bone marrow—thymus cancer	0.000142	0.000738	CbGeAlD
Sunitinib—CSF1R—thyroid gland—thymus cancer	0.000141	0.000736	CbGeAlD
Sunitinib—KIT—lymphoid tissue—thymus cancer	0.000141	0.000736	CbGeAlD
Sunitinib—LRRK2—lymph node—thymus cancer	0.000141	0.000733	CbGeAlD
Sunitinib—PRKAA1—lymph node—thymus cancer	0.000139	0.000723	CbGeAlD
Sunitinib—PDGFRB—lymphoid tissue—thymus cancer	0.000138	0.000718	CbGeAlD
Sunitinib—PTK2B—lymph node—thymus cancer	0.000137	0.000714	CbGeAlD
Sunitinib—FLT4—lymph node—thymus cancer	0.000137	0.000712	CbGeAlD
Sunitinib—CSNK1E—lymph node—thymus cancer	0.000135	0.000703	CbGeAlD
Sunitinib—FGFR1—lymph node—thymus cancer	0.000135	0.000703	CbGeAlD
Sunitinib—IRAK4—lymph node—thymus cancer	0.000133	0.000692	CbGeAlD
Sunitinib—KDR—lung—thymus cancer	0.000131	0.000685	CbGeAlD
Sunitinib—MAP2K5—lung—thymus cancer	0.000131	0.000685	CbGeAlD
Sunitinib—ULK3—lymph node—thymus cancer	0.00013	0.000677	CbGeAlD
Sunitinib—MAP2K2—lymph node—thymus cancer	0.00013	0.000677	CbGeAlD
Sunitinib—MAP3K2—lymph node—thymus cancer	0.000129	0.000672	CbGeAlD
Sunitinib—KIT—bone marrow—thymus cancer	0.000129	0.00067	CbGeAlD
Sunitinib—CSF1R—lung—thymus cancer	0.000128	0.000668	CbGeAlD
Sunitinib—KIT—thyroid gland—thymus cancer	0.000128	0.000668	CbGeAlD
Sunitinib—MAP3K7—lymph node—thymus cancer	0.000128	0.000665	CbGeAlD
Sunitinib—TBK1—lymph node—thymus cancer	0.000126	0.000658	CbGeAlD
Sunitinib—PDGFRB—bone marrow—thymus cancer	0.000126	0.000654	CbGeAlD
Sunitinib—TYK2—lymph node—thymus cancer	0.000125	0.000653	CbGeAlD
Sunitinib—PDGFRB—thyroid gland—thymus cancer	0.000125	0.000653	CbGeAlD
Sunitinib—IRAK1—lymph node—thymus cancer	0.000124	0.000645	CbGeAlD
Sunitinib—KCNH2—hematopoietic system—thymus cancer	0.000124	0.000645	CbGeAlD
Sunitinib—RPS6KB1—lymph node—thymus cancer	0.000121	0.000633	CbGeAlD
Sunitinib—FGR—lymph node—thymus cancer	0.000121	0.000629	CbGeAlD
Sunitinib—RET—lymph node—thymus cancer	0.000121	0.000629	CbGeAlD
Sunitinib—AXL—lymph node—thymus cancer	0.00012	0.000626	CbGeAlD
Sunitinib—KIT—lung—thymus cancer	0.000116	0.000607	CbGeAlD
Sunitinib—SLK—lymph node—thymus cancer	0.000116	0.000603	CbGeAlD
Sunitinib—JAK2—lymph node—thymus cancer	0.000114	0.000595	CbGeAlD
Sunitinib—PDGFRB—lung—thymus cancer	0.000114	0.000593	CbGeAlD
Sunitinib—FYN—lymph node—thymus cancer	0.000113	0.000586	CbGeAlD
Sunitinib—MAP4K5—lymph node—thymus cancer	0.00011	0.000573	CbGeAlD
Sunitinib—MAP3K3—lymph node—thymus cancer	0.00011	0.000573	CbGeAlD
Sunitinib—FLT1—lymph node—thymus cancer	0.000106	0.000554	CbGeAlD
Sunitinib—EPHB6—lymph node—thymus cancer	0.000105	0.000548	CbGeAlD
Sunitinib—CYP3A5—hematopoietic system—thymus cancer	0.000102	0.000532	CbGeAlD
Sunitinib—YES1—lymph node—thymus cancer	0.000102	0.000529	CbGeAlD
Sunitinib—STK10—lymph node—thymus cancer	0.000101	0.000524	CbGeAlD
Sunitinib—TAOK3—lymph node—thymus cancer	0.0001	0.000522	CbGeAlD
Sunitinib—ABCC4—bone marrow—thymus cancer	0.0001	0.000521	CbGeAlD
Sunitinib—ABCC4—thyroid gland—thymus cancer	9.97e-05	0.00052	CbGeAlD
Sunitinib—PDGFRA—lymph node—thymus cancer	9.96e-05	0.000519	CbGeAlD
Sunitinib—KCNH2—cardiac atrium—thymus cancer	9.4e-05	0.00049	CbGeAlD
Sunitinib—KCNH2—pituitary gland—thymus cancer	9.18e-05	0.000478	CbGeAlD
Sunitinib—ABCC4—lung—thymus cancer	9.06e-05	0.000472	CbGeAlD
Sunitinib—MAP2K5—lymph node—thymus cancer	8.99e-05	0.000468	CbGeAlD
Sunitinib—KDR—lymph node—thymus cancer	8.99e-05	0.000468	CbGeAlD
Sunitinib—CSF1R—lymph node—thymus cancer	8.77e-05	0.000457	CbGeAlD
Sunitinib—ABCG2—pituitary gland—thymus cancer	8.17e-05	0.000425	CbGeAlD
Sunitinib—KIT—lymph node—thymus cancer	7.97e-05	0.000415	CbGeAlD
Sunitinib—KCNH2—bone marrow—thymus cancer	7.93e-05	0.000413	CbGeAlD
Sunitinib—PDGFRB—lymph node—thymus cancer	7.78e-05	0.000405	CbGeAlD
Sunitinib—CYP3A4—hematopoietic system—thymus cancer	7.67e-05	0.0004	CbGeAlD
Sunitinib—ABCG2—bone marrow—thymus cancer	7.06e-05	0.000368	CbGeAlD
Sunitinib—ABCG2—thyroid gland—thymus cancer	7.04e-05	0.000367	CbGeAlD
Sunitinib—ABCG2—lung—thymus cancer	6.39e-05	0.000333	CbGeAlD
Sunitinib—ABCC4—lymph node—thymus cancer	6.19e-05	0.000323	CbGeAlD
Sunitinib—ABCC2—lymph node—thymus cancer	6e-05	0.000312	CbGeAlD
Sunitinib—CYP3A5—lung—thymus cancer	5.93e-05	0.000309	CbGeAlD
Sunitinib—ABCB1—hematopoietic system—thymus cancer	5.43e-05	0.000283	CbGeAlD
Sunitinib—ABCB1—epithelium—thymus cancer	4.96e-05	0.000259	CbGeAlD
Sunitinib—KCNH2—lymph node—thymus cancer	4.92e-05	0.000256	CbGeAlD
Sunitinib—ABCG2—lymph node—thymus cancer	4.37e-05	0.000228	CbGeAlD
Sunitinib—ABCB1—pituitary gland—thymus cancer	4.03e-05	0.00021	CbGeAlD
Sunitinib—ABCB1—lymphoid tissue—thymus cancer	3.82e-05	0.000199	CbGeAlD
Sunitinib—ABCB1—bone marrow—thymus cancer	3.48e-05	0.000181	CbGeAlD
Sunitinib—ABCB1—thyroid gland—thymus cancer	3.47e-05	0.000181	CbGeAlD
Sunitinib—ABCB1—lung—thymus cancer	3.15e-05	0.000164	CbGeAlD
Sunitinib—ABCB1—lymph node—thymus cancer	2.16e-05	0.000112	CbGeAlD
Sunitinib—FGFR1—Disease—KIT—thymus cancer	1.07e-05	7.26e-05	CbGpPWpGaD
Sunitinib—BLK—Adaptive Immune System—AKT1—thymus cancer	1.07e-05	7.26e-05	CbGpPWpGaD
Sunitinib—PHKG2—Metabolism—AKT1—thymus cancer	1.07e-05	7.24e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—KIT—thymus cancer	1.07e-05	7.24e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—KIT—thymus cancer	1.07e-05	7.24e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—CD4—thymus cancer	1.05e-05	7.1e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—KIT—thymus cancer	1.05e-05	7.09e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—KIT—thymus cancer	1.05e-05	7.09e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—KIT—thymus cancer	1.04e-05	7.07e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—AKT1—thymus cancer	1.02e-05	6.95e-05	CbGpPWpGaD
Sunitinib—STK11—Metabolism—AKT1—thymus cancer	1.02e-05	6.94e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—KIT—thymus cancer	1.02e-05	6.91e-05	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—AKT1—thymus cancer	1.01e-05	6.88e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—TP53—thymus cancer	1.01e-05	6.88e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—AKT1—thymus cancer	1.01e-05	6.88e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—KIT—thymus cancer	1e-05	6.81e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—KIT—thymus cancer	9.99e-06	6.77e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—AKT1—thymus cancer	9.96e-06	6.76e-05	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—AKT1—thymus cancer	9.95e-06	6.75e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD4—thymus cancer	9.92e-06	6.73e-05	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—AKT1—thymus cancer	9.87e-06	6.7e-05	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—AKT1—thymus cancer	9.87e-06	6.7e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—KIT—thymus cancer	9.85e-06	6.69e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—TP53—thymus cancer	9.76e-06	6.62e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL2—thymus cancer	9.7e-06	6.58e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD4—thymus cancer	9.63e-06	6.53e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL2—thymus cancer	9.62e-06	6.53e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—KIT—thymus cancer	9.62e-06	6.52e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—KIT—thymus cancer	9.54e-06	6.47e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—TP53—thymus cancer	9.52e-06	6.46e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD4—thymus cancer	9.51e-06	6.45e-05	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—AKT1—thymus cancer	9.36e-06	6.35e-05	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—AKT1—thymus cancer	9.34e-06	6.34e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD4—thymus cancer	9.34e-06	6.34e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD4—thymus cancer	9.34e-06	6.34e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL2—thymus cancer	9.3e-06	6.31e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TP53—thymus cancer	9.27e-06	6.29e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TP53—thymus cancer	9.27e-06	6.29e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—KIT—thymus cancer	9.27e-06	6.29e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—KIT—thymus cancer	9.22e-06	6.25e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL2—thymus cancer	9.13e-06	6.19e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—AKT1—thymus cancer	9.1e-06	6.18e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TP53—thymus cancer	8.99e-06	6.1e-05	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—AKT1—thymus cancer	8.96e-06	6.08e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—AKT1—thymus cancer	8.92e-06	6.05e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—CD4—thymus cancer	8.89e-06	6.03e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD4—thymus cancer	8.87e-06	6.01e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL2—thymus cancer	8.86e-06	6.01e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD4—thymus cancer	8.84e-06	6e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—KIT—thymus cancer	8.84e-06	6e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—KIT—thymus cancer	8.81e-06	5.98e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—CD4—thymus cancer	8.78e-06	5.96e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL2—thymus cancer	8.75e-06	5.94e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL2—thymus cancer	8.73e-06	5.92e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TP53—thymus cancer	8.65e-06	5.87e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL2—thymus cancer	8.65e-06	5.87e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—CD4—thymus cancer	8.62e-06	5.85e-05	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—AKT1—thymus cancer	8.6e-06	5.84e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—AKT1—thymus cancer	8.6e-06	5.83e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL2—thymus cancer	8.59e-06	5.83e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL2—thymus cancer	8.59e-06	5.83e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—AKT1—thymus cancer	8.56e-06	5.81e-05	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—AKT1—thymus cancer	8.5e-06	5.77e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KIT—thymus cancer	8.39e-06	5.69e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Metabolism—AKT1—thymus cancer	8.38e-06	5.68e-05	CbGpPWpGaD
Sunitinib—TBK1—Immune System—AKT1—thymus cancer	8.37e-06	5.68e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TP53—thymus cancer	8.3e-06	5.63e-05	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—AKT1—thymus cancer	8.25e-06	5.6e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—AKT1—thymus cancer	8.24e-06	5.59e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	8.23e-06	5.58e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TP53—thymus cancer	8.22e-06	5.58e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL2—thymus cancer	8.22e-06	5.58e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—AKT1—thymus cancer	8.21e-06	5.57e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CD4—thymus cancer	8.18e-06	5.55e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CD4—thymus cancer	8.16e-06	5.54e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD4—thymus cancer	8.16e-06	5.54e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL2—thymus cancer	8.16e-06	5.53e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—AKT1—thymus cancer	8.15e-06	5.53e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KIT—thymus cancer	8.14e-06	5.52e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL2—thymus cancer	8.14e-06	5.52e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—IL2—thymus cancer	8.09e-06	5.49e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KIT—thymus cancer	8.04e-06	5.45e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—AKT1—thymus cancer	8.04e-06	5.45e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—AKT1—thymus cancer	8.02e-06	5.44e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—AKT1—thymus cancer	8e-06	5.43e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—AKT1—thymus cancer	8e-06	5.43e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD4—thymus cancer	7.97e-06	5.4e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—AKT1—thymus cancer	7.94e-06	5.39e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL2—thymus cancer	7.92e-06	5.38e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—AKT1—thymus cancer	7.92e-06	5.37e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KIT—thymus cancer	7.9e-06	5.36e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TP53—thymus cancer	7.84e-06	5.32e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—AKT1—thymus cancer	7.83e-06	5.31e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—AKT1—thymus cancer	7.83e-06	5.31e-05	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—AKT1—thymus cancer	7.82e-06	5.31e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TP53—thymus cancer	7.76e-06	5.26e-05	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—AKT1—thymus cancer	7.72e-06	5.23e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL2—thymus cancer	7.69e-06	5.22e-05	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—AKT1—thymus cancer	7.68e-06	5.21e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—AKT1—thymus cancer	7.68e-06	5.21e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD4—thymus cancer	7.68e-06	5.21e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD4—thymus cancer	7.64e-06	5.18e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL2—thymus cancer	7.63e-06	5.18e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—AKT1—thymus cancer	7.59e-06	5.15e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—AKT1—thymus cancer	7.59e-06	5.15e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL2—thymus cancer	7.58e-06	5.14e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—AKT1—thymus cancer	7.57e-06	5.14e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CD4—thymus cancer	7.54e-06	5.11e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL2—thymus cancer	7.51e-06	5.1e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KIT—thymus cancer	7.49e-06	5.08e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KIT—thymus cancer	7.47e-06	5.07e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—AKT1—thymus cancer	7.46e-06	5.06e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—AKT1—thymus cancer	7.45e-06	5.05e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—AKT1—thymus cancer	7.41e-06	5.03e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TP53—thymus cancer	7.39e-06	5.02e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CD4—thymus cancer	7.35e-06	4.99e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL2—thymus cancer	7.35e-06	4.99e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL2—thymus cancer	7.35e-06	4.99e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL2—thymus cancer	7.35e-06	4.99e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL2—thymus cancer	7.33e-06	4.97e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—AKT1—thymus cancer	7.31e-06	4.96e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD4—thymus cancer	7.3e-06	4.95e-05	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—AKT1—thymus cancer	7.29e-06	4.95e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—AKT1—thymus cancer	7.27e-06	4.93e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—AKT1—thymus cancer	7.25e-06	4.92e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—AKT1—thymus cancer	7.2e-06	4.89e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL2—thymus cancer	7.17e-06	4.86e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—CD4—thymus cancer	7.09e-06	4.81e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—AKT1—thymus cancer	7.08e-06	4.8e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL2—thymus cancer	7.06e-06	4.79e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CD4—thymus cancer	7.05e-06	4.78e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL2—thymus cancer	7.03e-06	4.77e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—AKT1—thymus cancer	7.01e-06	4.75e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—AKT1—thymus cancer	7.01e-06	4.75e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—AKT1—thymus cancer	6.99e-06	4.74e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TP53—thymus cancer	6.97e-06	4.73e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	6.95e-06	4.71e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—AKT1—thymus cancer	6.94e-06	4.71e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TP53—thymus cancer	6.92e-06	4.69e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KIT—thymus cancer	6.9e-06	4.68e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—AKT1—thymus cancer	6.82e-06	4.63e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—CD4—thymus cancer	6.74e-06	4.57e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KIT—thymus cancer	6.73e-06	4.57e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL2—thymus cancer	6.72e-06	4.56e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—AKT1—thymus cancer	6.65e-06	4.51e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—AKT1—thymus cancer	6.62e-06	4.49e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—AKT1—thymus cancer	6.58e-06	4.46e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—AKT1—thymus cancer	6.55e-06	4.45e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—AKT1—thymus cancer	6.55e-06	4.45e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—AKT1—thymus cancer	6.54e-06	4.44e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KIT—thymus cancer	6.49e-06	4.4e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—AKT1—thymus cancer	6.49e-06	4.4e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—AKT1—thymus cancer	6.47e-06	4.39e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KIT—thymus cancer	6.46e-06	4.38e-05	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—AKT1—thymus cancer	6.32e-06	4.28e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—AKT1—thymus cancer	6.25e-06	4.24e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—AKT1—thymus cancer	6.24e-06	4.24e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL2—thymus cancer	6.22e-06	4.22e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KIT—thymus cancer	6.17e-06	4.19e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TP53—thymus cancer	5.97e-06	4.05e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL2—thymus cancer	5.9e-06	4e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—AKT1—thymus cancer	5.89e-06	3.99e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—AKT1—thymus cancer	5.84e-06	3.96e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL2—thymus cancer	5.73e-06	3.89e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL2—thymus cancer	5.66e-06	3.84e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TP53—thymus cancer	5.6e-06	3.8e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL2—thymus cancer	5.56e-06	3.77e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL2—thymus cancer	5.56e-06	3.77e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TP53—thymus cancer	5.55e-06	3.77e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL2—thymus cancer	5.27e-06	3.58e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL2—thymus cancer	5.26e-06	3.57e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—AKT1—thymus cancer	5.26e-06	3.57e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—AKT1—thymus cancer	5.22e-06	3.54e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—thymus cancer	5.09e-06	3.45e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AKT1—thymus cancer	5.04e-06	3.42e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—thymus cancer	4.95e-06	3.36e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—thymus cancer	4.9e-06	3.33e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—thymus cancer	4.87e-06	3.3e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—thymus cancer	4.86e-06	3.29e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—thymus cancer	4.81e-06	3.26e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—thymus cancer	4.75e-06	3.22e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—thymus cancer	4.74e-06	3.21e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—thymus cancer	4.73e-06	3.21e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—thymus cancer	4.72e-06	3.2e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—thymus cancer	4.72e-06	3.2e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—thymus cancer	4.69e-06	3.18e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—thymus cancer	4.66e-06	3.16e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—thymus cancer	4.66e-06	3.16e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—thymus cancer	4.6e-06	3.12e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—thymus cancer	4.57e-06	3.1e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—thymus cancer	4.54e-06	3.08e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—thymus cancer	4.46e-06	3.02e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—thymus cancer	4.44e-06	3.01e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—thymus cancer	4.42e-06	3e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—thymus cancer	4.41e-06	2.99e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—thymus cancer	4.39e-06	2.98e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—thymus cancer	4.38e-06	2.97e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—thymus cancer	4.34e-06	2.95e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—thymus cancer	4.3e-06	2.92e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—thymus cancer	4.3e-06	2.92e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—thymus cancer	4.17e-06	2.83e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—thymus cancer	4.14e-06	2.81e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—thymus cancer	4.11e-06	2.79e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—thymus cancer	4.08e-06	2.77e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—thymus cancer	4.07e-06	2.76e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—thymus cancer	4.07e-06	2.76e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—thymus cancer	4e-06	2.71e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—thymus cancer	3.99e-06	2.71e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—thymus cancer	3.99e-06	2.71e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—thymus cancer	3.99e-06	2.7e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—thymus cancer	3.97e-06	2.7e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—thymus cancer	3.89e-06	2.64e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—thymus cancer	3.83e-06	2.6e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—thymus cancer	3.81e-06	2.59e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—thymus cancer	3.79e-06	2.57e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—thymus cancer	3.76e-06	2.55e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—thymus cancer	3.68e-06	2.5e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—thymus cancer	3.67e-06	2.49e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—thymus cancer	3.64e-06	2.47e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—thymus cancer	3.63e-06	2.46e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—thymus cancer	3.57e-06	2.42e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—thymus cancer	3.57e-06	2.42e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—thymus cancer	3.54e-06	2.4e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—thymus cancer	3.52e-06	2.39e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—thymus cancer	3.39e-06	2.3e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—thymus cancer	3.38e-06	2.29e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—thymus cancer	3.37e-06	2.29e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—thymus cancer	3.36e-06	2.28e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—thymus cancer	3.2e-06	2.17e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—thymus cancer	3.12e-06	2.12e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—thymus cancer	3.11e-06	2.11e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—thymus cancer	3.07e-06	2.08e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—thymus cancer	3.04e-06	2.06e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—thymus cancer	3.01e-06	2.04e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—thymus cancer	3.01e-06	2.04e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—thymus cancer	2.93e-06	1.99e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—thymus cancer	2.92e-06	1.98e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—thymus cancer	2.86e-06	1.94e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—thymus cancer	2.85e-06	1.94e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—thymus cancer	2.79e-06	1.89e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—thymus cancer	2.63e-06	1.79e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—thymus cancer	2.57e-06	1.74e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—thymus cancer	2.48e-06	1.68e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—thymus cancer	2.46e-06	1.67e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—thymus cancer	2.39e-06	1.62e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—thymus cancer	2.37e-06	1.61e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—thymus cancer	2.35e-06	1.6e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—thymus cancer	1.71e-06	1.16e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—thymus cancer	1.29e-06	8.76e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—thymus cancer	7.96e-07	5.4e-06	CbGpPWpGaD
